Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Osteoporosis Drugs Market Research Reports

Titlepublishedprice

Global Raloxifene Hydrochloride Market Research Report 2017

By QYResearch Group
"...... n, consumption, revenue (million USD), market share and growth rate of Raloxifene Hydrochloride in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - China - Japan - Southeast Asia......"
30-Mar-2017$2900

Osteoarthritis - Pipeline Review, H1 2017

By Global Markets Direct
"...... which the cartilage breaks down. Symptoms of osteoarthritis include sore or stiff joints, pain that is worse after activity, bone spurs and grating sensation. Risk factors include older age, joint injuries and obesity. Treatment includes surgery, me......"
08-Mar-2017$2000

Global Osteoporosis Partnering 2010 to 2017

By Current Partnering
"...... Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - Deals listed......"
01-Mar-2017$1495

Optinate -Drug Insights, 2017

By Delve Insight
"...... ovides the Optinate sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Optinate, patents information and exclusivity data, route of synthesis, competitive ......"
01-Jan-2017$1000

Optruma -Drug Insights, 2017

By Delve Insight
"...... des the Optruma sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Optruma, patents information and exclusivity data, route of synthesis, competitive lands......"
01-Jan-2017$1000

Osteoporosis - Market Insights, Epidemiology and Market Forecast-2023

By Delve Insight
"...... rapeutics market revenue; average cost of therapy, treatment practice and Osteoporosis forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Osteoporos......"
01-Jan-2017$4950

Prolia -Drug Insights, 2017

By Delve Insight
"...... the Prolia sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Prolia, patents information and exclusivity data, route of synthesis, competitive landscape,......"
01-Jan-2017$1000

Osteoporosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... understand the market and pipeline status of the drugs around the Osteoporosis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report pr......"
01-Jan-2017$2000

Post Menopausal Osteoporosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

By Delve Insight
"...... pausal Osteoporosis Report is to understand the market and pipeline status of the drugs around the Post Menopausal Osteoporosis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing p......"
01-Jan-2017$2000

Teribone -Drug Insights, 2017

By Delve Insight
"...... ovides the Teribone sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Teribone, patents information and exclusivity data, route of synthesis, competitive ......"
01-Jan-2017$1000